Fact CheckerSign in

NCT06749795Not yet recruitingPhase 1

LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)

A Randomized, Double-Blind, Placebo Controlled, Multi -Center, Phase 1b Study to Evaluate the Safety and Tolerability of LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis

Source: ClinicalTrials.gov · Last updated 24 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

A Phase 1b study to evaluate the safety and tolerability of LIV001 in Patients with Mild-to- Moderate Active Ulcerative Colitis

Status (registry)
Not yet recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
15 (estimated)
First submitted
17 Dec 2024
Start date
24 Mar 2025
Primary completion date
17 Jan 2026
Lead sponsor
Liveome Inc.
NCT number
NCT06749795

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 15
  • From 24 Mar 2025 to the primary completion date, 17 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of a condition associated with significant immunosuppression, or chronic administration (\> 14 consecutive days) of immunosuppressants or other immune-modifying drugs within 3 months prior to Visit 3 (subjects taking oral medications for UC, including corticosteroids or immunomodulators, are not excluded).

Other illness

  • Possible or confirmed diagnosis of Crohn's Disease, other form of inflammatory bowel disorder and coeliac disease.

Who the study is looking for

  • Male or female aged 18 to 65 years (inclusive) at Screening.
  • Established diagnosis of UC for at least 3 months prior to Screening, diagnosed by routine clinical, radiographic, endoscopic or pathologic criteria (Confirmed by colonoscopy and pathology records or, if unavailable, diagnosis confirmed by a letter from the subject's general practitioner.)

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska
Coordinator of this site? Confirm its status
WroclawPolandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.